Team:Trieste/parts/4
From 2012.igem.org
(Difference between revisions)
Line 36: | Line 36: | ||
<br/> | <br/> | ||
<br/> | <br/> | ||
- | <img src=" | + | <img src="" alt="Gel LPP-OmpA-scFv" width="450px"/> |
<br/><p class="didascalia"><strong>FIG.1 Electrophoresis in gel 1% agarose whit ethidium bromide of T5LacO-LPP-OmpA-scFv-6His-TT.</strong> Fragment LPP-OmpA-scFv-6His-TT, previously double digested in XbaI/PstI, has to be cloned downstream the T5LacOperator in plasmid pSB1C3 double digested in SpeI/PstI.> | <br/><p class="didascalia"><strong>FIG.1 Electrophoresis in gel 1% agarose whit ethidium bromide of T5LacO-LPP-OmpA-scFv-6His-TT.</strong> Fragment LPP-OmpA-scFv-6His-TT, previously double digested in XbaI/PstI, has to be cloned downstream the T5LacOperator in plasmid pSB1C3 double digested in SpeI/PstI.> | ||
</p> | </p> |
Revision as of 08:05, 26 September 2012
BBa_K875004
More
Description
This construct is designed for the expression of an already descibed engeneered antinorovirus (NoV) monoclonal antibody (mAb 54.6) in fusion with LPP-OmpA. The antibody is expressed in a single chain fragment variable (scFv) format containing light (VL) and heavy (VH) variable domains separeted by a flexible peptide linker. It has already been reported that the scFv 54.6 binds a native recombinant NoV particles (VLPs) and inhibits VLP interaction with cells. LPP-OmpA functions as a leader sequence and an anchor to display the scFv ot the bacterial surface.
The construct consistes of T5 Lac Operator (Bba_K875002), ribosomal binding site, LPP-OmpA, scFv 54.6 antinorovirus, Hystidine tag (6HIS), Terminator (B0015).
The expression of chimeric protein LPP-OmpA-scFv 54.6-His is regulated by T5 Lac Operator (Bba_K875002). When the promoter T5LacO is induced with IPTG (1mM), the fusion protein LPP-OmpA-scFv 54.6-His is expressed extracellularly on the bacterial surface. LPP-OmpA introduces itself into outer membrane displaying extracellularly antibody attached on itc C-terminus. The number of scFv attached on the bacterial surface, when regulated by this promoter, is estimated up to 30 000*. This protein has 45.19 kDa.
Assembly
Obtained by synthesis.Results
The cloning success has been verified by Colony PCR. (Fig. 1) The construct has been completely sequenced.FIG.1 Electrophoresis in gel 1% agarose whit ethidium bromide of T5LacO-LPP-OmpA-scFv-6His-TT. Fragment LPP-OmpA-scFv-6His-TT, previously double digested in XbaI/PstI, has to be cloned downstream the T5LacOperator in plasmid pSB1C3 double digested in SpeI/PstI.>
The construct was tested in E.coli W3110 strain which was previously trasformed with p-REP 4 encoding for the T5 Lac Repressor. The recombinant bacterial colonies were induced at O.D.= 0.4 (2x102 bacterial cells/ml) with IPTG (1mM) at 37°C in shaker. 2ml of bacterial culture was centrifucated and the pellet was resuspended in 200μl of lysis buffer. The samples were then sonificated and boiled for 5 min at 95°C. 10μl of lysates of induced, non-induced and non trasformed bacterial coltures were resolved on SDS-PAGE. The expression of fusion protein LPP-OmpA-scFv 54.6-His was tested by Western blotting with anti-6HIS antibodies (Fig. 2).FIG. 1. Expression of scFv 54.6 cloned in fusion with the LPP-OmpA leader sequence . Western blots of lysates of E.coli W3110 bacterial strain expressing the recombinant protein scFv 54.6, induced or non-induced with IPTG. The blot was reacted with the monoclonal F24-796 anti-6XHIS antibody.
Western blot with anti-6HIS antibodies showed the band corresponding to SIP 54.6 at the expected position in the IPTG-induced sample. In the non-induced sample, a weaker signal is also detected suggesting that the promoter is leaky; aspecific signals are also visible. Some of them are due to proteins partially degraded. Reference: 1. “Transport and anchoring of 8-lactamase to the external surface of Escherichia coli” J. A. Francisco, C. F. Earhart and G. Georgiou. Proc. Natl. Acad. Sci. USA Vol. 89, pp. 2713-2717, April 1992 Biochemistry. 2. “Recombinant norovirus-specific scFv inhibit virus-like particle binding to cellular ligands” K. Ettayebi and M. E. Hardy. Published: 31 January 2008 in Virology Journal 2008, 5:21